Biomarkers in progressive fibrosing interstitial lung disease: optimizing diagnosis, prognosis, and treatment response
WS Bowman, GA Echt, JM Oldham - Frontiers in Medicine, 2021 - frontiersin.org
Interstitial lung disease (ILD) comprises a heterogenous group of diffuse lung disorders that
commonly result in irreversible pulmonary fibrosis. While idiopathic pulmonary fibrosis (IPF) …
commonly result in irreversible pulmonary fibrosis. While idiopathic pulmonary fibrosis (IPF) …
Serum biomarkers of lung fibrosis in interstitial pneumonia with autoimmune features—what do we already know?
E Miądlikowska, P Rzepka-Wrona… - Journal of Clinical …, 2021 - mdpi.com
Interstitial pneumonia with autoimmune features (IPAF) belongs to a group of diseases
called interstitial lung diseases (ILDs), which are disorders of a varied prognosis and course …
called interstitial lung diseases (ILDs), which are disorders of a varied prognosis and course …
Evaluation of the diagnostic efficacies of serological markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in idiopathic interstitial pneumonia
M Xue, Z Guo, C Cai, B Sun, H Wang - Respiration, 2019 - karger.com
Background: The objective of this study was to evaluate the diagnostic value of serological
markers Krebs von den Lungen-6 (KL-6), surfactant protein-A (SP-A), SP-D, chemokine …
markers Krebs von den Lungen-6 (KL-6), surfactant protein-A (SP-A), SP-D, chemokine …
Celastrol: A lead compound that inhibits SARS‐CoV‐2 replication, the activity of viral and human cysteine proteases, and virus‐induced IL‐6 secretion
The global emergence of coronavirus disease 2019 (COVID‐19) has caused substantial
human casualties. Clinical manifestations of this disease vary from asymptomatic to lethal …
human casualties. Clinical manifestations of this disease vary from asymptomatic to lethal …
[HTML][HTML] Krebs von den Lungen-6 and surfactant protein-A in interstitial pneumonia with autoimmune features
M Xue, C Cai, Y Zeng, Y Xu, H Chen, H Hu, L Zhou… - Medicine, 2021 - journals.lww.com
Interstitial pneumonia with autoimmune features (IPAF) is a special subtype of interstitial
lung disease that has received worldwide attention. Krebs von den Lungen-6 (KL-6) and …
lung disease that has received worldwide attention. Krebs von den Lungen-6 (KL-6) and …
A genomic perspective of the aging human and mouse lung with a focus on immune response and cellular senescence
M He, J Borlak - Immunity & Ageing, 2023 - Springer
Background The aging lung is a complex process and influenced by various stressors,
especially airborne pathogens and xenobiotics. Additionally, a lifetime exposure to antigens …
especially airborne pathogens and xenobiotics. Additionally, a lifetime exposure to antigens …
[HTML][HTML] The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin …
RC Russo, B Ryffel - Cells, 2024 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a chronic and lethal interstitial lung disease (ILD) of
unknown origin, characterized by limited treatment efficacy and a fibroproliferative nature. It …
unknown origin, characterized by limited treatment efficacy and a fibroproliferative nature. It …
High Interleukin-13 level is associated with disease stability in interstitial Lung disease
EK Joerns, D Karp, S Zhang, JA Sparks, TN Adams… - Heliyon, 2024 - cell.com
Abstract (144/150 words) Purpose Cytokines can help predict prognosis in interstitial lung
disease (ILD) and to differentiate between ILD subtypes. The objectives of our study were to …
disease (ILD) and to differentiate between ILD subtypes. The objectives of our study were to …
CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study
N Enomoto, S Nakai, S Yazawa, Y Mochizuka… - Respiratory …, 2024 - Springer
Background Interstitial pneumonia with autoimmune features (IPAF), which does not meet
any of the criteria for connective tissue diseases (CTD), has been attracting an attention in …
any of the criteria for connective tissue diseases (CTD), has been attracting an attention in …
Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases
S Barril, P Acebo, P Millan-Billi, A Luque, O Sibila… - Respiratory …, 2023 - Springer
Abstract Background Pulmonary Langerhans cell histiocytosis (PLCH) is a rare interstitial
lung disease (ILD) associated with smoking, whose definitive diagnosis requires the …
lung disease (ILD) associated with smoking, whose definitive diagnosis requires the …